Indoloquinazolinones

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C514S252160, C514S257000, C544S115000, C544S246000

Reexamination Certificate

active

06964960

ABSTRACT:
The invention provides compounds of formula (I) wherein R is as defined in the description, and the preparation thereof. The compounds of formula (I) are useful as pharmaceuticals, for use in the treatment of any state associated with high levels of activeted PARP.

REFERENCES:
patent: 5441955 (1995-08-01), Baker et al.
patent: 1309 485 (1973-03-01), None
patent: 1 428 488 (1976-03-01), None
patent: WO 95 24379 (1995-09-01), None
Abdelkarim GE, Gertz K, Harms C, Katchanov J, Dirnagl U, Szabo C, Endres M., Int J Mol Med. Mar. 2001;7(3):255-60, Medline Abstract PMID: 11179503.
Alexander Bürkle, BioEssays vol. 23, Issue 9, pp. 795-806.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Indoloquinazolinones does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Indoloquinazolinones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Indoloquinazolinones will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-3511693

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.